COM:SAGERX
Sage Therapeutics
- Stock
locale
United Statesmarket
STOCKSindustry
Biotechnologywebsite
www.sagerx.com/ipo date
Jul 18, 2014
Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on brain health medicines. The company is targeting diseases and disorders of the brain with three key focus areas: depression, neurology and neuropsychiatry; also targeting two critical central nervous system, or CNS, receptor systems, GABA and NMDA. Its products ZURZUVAE is a medicine for the treatmen...Show More